Alves S, Regulier E, Nascimento-Ferreira I, Hassig R, Dufour N, Koeppen A, et al
Ray 1999
As we age, our bodies become less efficient at producing peptides, and the quality and quantity decreases over time
T3 is the active thyroid hormone that binds to thyroid receptors in the nucleus of cells, where DNA is used to make proteins that regulate the cells metabolism (the metabolic rate)
However, the combined inhibition of ASIC1a and CP-AMPARs is insufficient to restore the normal activity of neurons and ASIC1a and CP-AMPARs may thus be drug targets for neuroprotection [53]
193 These studies prove that PRMTs are potential targets for cancer therapy, and several PRMTs inhibitors are currently in clinical trials (Table 1)